Clik here to view.
ICURE、アルツハイマー型認知症治療のドネペジルパップ剤が世界初で品目許可の承認を獲得
韓国ソウル （ビジネスワイヤ） – 韓国の製薬会社ICURE (KOSDAQ: 175250)は、開発したアルツハイマー型認知症治療剤ドネペジル（Donepezil）パップ剤が...
View ArticleClik here to view.
Guided Therapeutics Announces Start of Chinese Clinical Trial for Approval to...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that enrollment and...
View ArticleClik here to view.
ICURE用于治疗阿尔茨海默氏症痴呆的多奈哌齐贴剂全球首次获得品种许可批准
韩国首尔 (美国商业资讯)–韩国制药厂商ICURE(KOSDAQ: 175250)日前发布消息称，其开发的阿尔茨海默氏症痴呆治疗药物多奈哌齐(Donepezil)贴剂已获得韩国食品医药品安全处颁发的正式品种许可。4月份提出申请之后，仅仅约7个月就获得了多奈哌齐贴剂的品种许可批准，ICURE凭借此次获批，收获了多奈哌齐贴剂全球首次成功实现商业化的头衔。...
View ArticleClik here to view.
美国FDA核准BESREMi® (Ropeginterferon α-2b)
维也纳 (美国商业资讯)–2009年，AOP Orphan获得独家授权，可在欧洲、独立国家联合体(CIS)和中东市场开展Ropeginterferon...
View ArticleClik here to view.
TROPION-Breast01 Phase 3 Trial of Datopotamab Deruxtecan Initiated in...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the first patient was dosed in the global TROPION-Breast01 phase 3 trial...
View ArticleClik here to view.
Quizartinib Added to Chemotherapy Demonstrates Superior Overall Survival...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced positive topline results from the global pivotal QuANTUM-First phase 3 trial...
View ArticleClik here to view.
Qurient Announces Collaboration Agreement with MSD to Evaluate Selective...
SEONGNAM-SI, Korea Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the company has entered into a clinical collaboration agreement with MSD, a...
View ArticleClik here to view.
Exscientia公布2021年第三季度业务更新
英格兰牛津 (美国商业资讯)–Exscientia (Nasdaq: EXAI)： 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20211122006704/zh-CN/ （图示：美国商业资讯）...
View ArticleClik here to view.
凌腾医药宣布，卡妥索双抗用于介苗治疗失败的非肌层浸润性膀胱癌的1期临床试验已完成首例患者给药
中国广州 (美国商业资讯)–凌腾医药(LintonPharm Co., Ltd.)是一家总部位于中国的临床阶段生物制药公司，专注于开发用于癌症免疫疗法的T细胞衔接双特异性抗体。公司今天宣布，单克隆双特异性抗体卡妥索双抗(catumaxomab)用于卡介苗(BCG)治疗失败的非肌层浸润性膀胱癌(Non-Muscle Invasive Bladder Cancer,...
View ArticleClik here to view.
BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment...
View ArticleClik here to view.
BeiGene Presents Updated Safety and Efficacy Findings on BRUKINSA...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines, today presented...
View ArticleClik here to view.
Valemetostat Pivotal Data Shows Promising Response Rates in Patients with...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that valemetostat, a potential first-in-class dual inhibitor of EZH1 and EZH2,...
View ArticleClik here to view.
BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment...
View ArticleClik here to view.
Two-Year Analysis of CARTITUDE-1 Shows Early, Durable and Deepening Responses...
SOMERSET, N.J. Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today new and...
View ArticleClik here to view.
Nanjing Leads Biolabs and BeiGene Announce Worldwide License and...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment...
View ArticleClik here to view.
Numab and 3SBio’s Sunshine Guojian Expand Partnership to Develop Novel T Cell...
WÄDENSWIL, Switzerland, SHENYANG, China, & SHANGHAI Numab Therapeutics AG (Numab) and 3SBio Inc. (“3SBio”, HKEX:1530) announced today that 3SBio’s subsidiary Sunshine Guojian Pharmaceutical...
View ArticleClik here to view.
BostonGene and NEC Announce Global Partnership
TOKYO & WALTHAM, Mass. BostonGene Corporation and NEC Corporation (NEC; TSE: 6701) today announced a strategic global partnership agreement that will enable the companies to offer BostonGene...
View ArticleClik here to view.
Dr. Reddy’s and Prestige BioPharma announce partnership to commercialize...
HYDERABAD, India Prestige BioPharma and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as “Dr. Reddy’s”) today announced that the two...
View ArticleClik here to view.
Personalis推出基于肿瘤信息的液相活检分析法NeXT Personal™，检测MRD和复发的灵敏度可达百万分之一
加州门洛帕克 (美国商业资讯)–先进癌症基因组学的领导者Personalis, Inc. (Nasdaq: PSNL)今天宣布推出NeXT Personal，这是一种新一代基于肿瘤信息的液相活检分析方法，旨在检测和量化有既往癌症诊断史患者的分子残留疾病(MRD)和复发。NeXT...
View ArticleClik here to view.
BeiGene Expands Collaboration with Novartis to Develop and Commercialize...
BASEL, Switzerland & CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced an option,...
View Article